| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Department of Nuclear Medicine, Erasme Hospital, Université Libre de Bruxelles, Brussels (RM-R); Médecins Sans Frontières (CS, FM, and FB), Brussels; the Prince Leopold Institute of Tropical Medicine, Antwerp, Belgium (MB); the Laboratory of Pharmaceutical Chemistry, Institute of Pharmacy, Université Libre de Buxelles, Brussels (MTR and JN); the Department of Pediatric Radiology, Children’s University Hospital, Université Libre de Bruxelles, Brussels (NP); and the Public Health School, Université Libre de Bruxelles, Brussels, and Ambroise Paré Hospital, Mons, Belgium (JV).
Background: Kashin-Beck disease is an osteoarthropathy endemic in selenium- and iodine-deficient areas around Lhasa, Tibet.
Objective: We assessed the efficacy of selenium supplementation on disease progression.
Design: A double-blind, randomized controlled trial of selenium supplementation was carried out in 324 children aged 5–15 y who had Kashin-Beck disease. Two hundred eighty children received iodized oil before being randomly assigned to receive selenium or placebo, and a control group of 44 subjects was not supplemented at all. Clinical and radiologic signs, selenium status, urinary iodine, and thyroid function were evaluated at baseline and at 12 mo.
Results: The frequencies of joint pain, decreased joint mobility, and radiologic abnormalities were not significantly different between the 3 groups at 12 mo. Height-for-age z scores increased significantly in the subjects who received placebo and iodine or selenium and iodine. In contrast, unsupplemented control subjects did not recover from growth retardation. Serum selenium concentrations at 12 mo were within the reference range and were significantly greater in the selenium-iodine group than in the placebo-iodine group. Serum thyroid hormone concentrations were within the reference ranges after the administration of iodine, and these values were not significantly affected by selenium supplementation.
Conclusions: The results of this study do not rule out the possibility that selenium may help to prevent the occurrence of Kashin-Beck disease. However, selenium supplementation had no effect on established Kashin-Beck disease, growth, or thyroid function once iodine deficiency was corrected. These results suggest that iodine, but not selenium, deficiency should be corrected in Tibetan children with Kashin-Beck disease.
Key Words: Selenium • iodine • Kashin-Beck disease • osteoarthropathy • Tibet
This article has been cited by other articles:
|
|
 |
|
  M. B. Zimmermann, P. L. Jooste, N. S. Mabapa, X. Mbhenyane, S. Schoeman, R. Biebinger, N. Chaouki, M. Bozo, L. Grimci, and J. Bridson Treatment of Iodine Deficiency in School-Age Children Increases Insulin-Like Growth Factor (IGF)-I and IGF Binding Protein-3 Concentrations and Improves Somatic Growth J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 437 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Moreno-Reyes, D. Egrise, M. Boelaert, S. Goldman, and S. Meuris Iodine Deficiency Mitigates Growth Retardation and Osteopenia in Selenium-Deficient Rats J. Nutr., March 1, 2006; 136(3): 595 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kohrle, F. Jakob, B. Contempre, and J. E. Dumont Selenium, the Thyroid, and the Endocrine System Endocr. Rev., December 1, 2005; 26(7): 944 - 984. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Xia, K. E Hill, D. W Byrne, J. Xu, and R. F Burk Effectiveness of selenium supplements in a low-selenium area of China Am. J. Clinical Nutrition, April 1, 2005; 81(4): 829 - 834. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
